Defunct Company
Total Trials
10
As Lead Sponsor
7
As Collaborator
3
Total Enrollment
176
NCT01719523
Open-Trial of EPI-743 for Adults With Tourette Syndrome
Phase: Phase 1
Role: Collaborator
Start: Oct 31, 2012
Completion: Oct 31, 2013
NCT01822249
Phase 2 Study of EPI-743 for Treatment of Rett Syndrome
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2013
Completion: Jan 31, 2014
NCT01923584
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
Start: Sep 30, 2013
Completion: Jun 30, 2016
NCT01962363
EPI-743 in Friedreich's Ataxia Point Mutations
Start: Oct 31, 2013
NCT02104336
Phase 2 Study of EPI-743 in Children With Pearson Syndrome
Start: Aug 31, 2014
Completion: Feb 29, 2016
NCT02226458
An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Start: Oct 31, 2014
Completion: Jan 31, 2016
NCT02257983
Protective Effects of EPI-743 on Noise-Induced Hearing Loss
NCT02360436
Analysis of the Glutathione Cycle in Children With Rett Syndrome
Phase: N/A
Start: Mar 31, 2015
Completion: Sep 30, 2015
NCT02462603
Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease
Start: May 17, 2016
Completion: Jan 8, 2019